Purchase Order HHSN276201500478P
Award Date 7/31/15
Potential Completion Date 8/4/15
Potential Value $48K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Australia
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of genetically modified mice and related services to support biomedical research. The $2,024 firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. Ozgene, the prime contractor, will deliver gene targeting vectors, mouse backcrossing, and the creation...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $57,600 firm-fixed-price contract was for the generation of conditional gene knockout and knockin mouse models to support biomedical research. Ozgene, as the prime contractor, will provide gene targeting vector design and creation, mouse...
- This federal contract award is for Ozgene Pty Ltd, an Australian company that provides genetically modified mice and related services to support biomedical research. The award, valued at $6,193.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is a delivery order for the production of gene knockout and gene knock-in male mice to be crossed with female...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The $7,286.00 firm fixed-price delivery order contract supports additional breeding and other services related to the development of genetically modified mice for biomedical research. Ozgene, the prime contractor, provides gene targeting vectors, mouse...
- The federal contract award is to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The award was made by the National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Child Health and Human Development (NICHD), to deliver gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice. The...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the delivery of genetically modified mice and related services to support biomedical research at various institutes and centers within the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The specific services provided under this $5,970.00 firm fixed price delivery order contract include gene targeting vector design and creation, mouse embryonic stem cell generation, blastocyst...
- This federal contract award to Ozgene PTY LTD, an Australian company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The $65,800 firm fixed-price delivery order is for the provision of genetically modified mouse strains to support biomedical research. Ozgene, the prime contractor, specializes in gene targeting, knockout, and knock-in mouse models....
- This is a definitive contract awarded by the National Institutes of Health (NIH) to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $38,945,214.78, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice to support research into various diseases and disorders, such as hemoglobin disorders, red blood cell development,...
- This is a federal contract award to Ozgene PTY LTD, an Australian company that provides genetically modified mice and related services to support biomedical research. The contract, valued at $1,504.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services' National Institutes of Health (NIH). The contract is for Ozgene to maintain a small colony of mice for a 12-week period, including mating wild-type and...
- This federal contract award to Ozgene PTY LTD, an Australian company, is for the provision of gene targeting vectors, mouse backcrossing, and the creation of gene knockout and gene knock-in mice in support of biomedical research. The $70,800.00 firm fixed-price contract was awarded on June 2, 2011 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The work supports research...